Crop protection specialist Exosect has announced two new appointments at the company.
David Richardson joins Exosect as financial director. With more than 20 years financial experience, a qualified accountant and treasurer, Richardson’s experience has been focused in the bio-technology sector working for a number of companies including Evotec AG, Zeneca Cellmark Diagnostics and Marlow Foods then part of ICI Biological Products.
Peter Keen was recently appointed as Exosect’s new non-executive chairman. Keen is a chartered accountant and brings with him more than 25 years experience in financing and management of companies within the emerging bio-technology and pharmaceuticals sectors.
He is currently a non-executive director of Ark Therapeutics Groups PLC, Biotechnology Growth Trust plc (“BGT) and Abcam plc which he joined prior to the companies’ IPO. He is also the non-executive director of Serentis Ltd. Previously he was the chief financial officer at Arakis until its sale in 2005.
